Literature DB >> 19426770

Transcutaneous immunization using common chemicals.

Pankaj Karande1, Anubhav Arora, Thien Kahn Pham, Daniel Stevens, Arthur Wojicki, Samir Mitragotri.   

Abstract

Transcutaneous immunization, topical application of vaccines on skin, provides several advantages over needle based immunization. However, simple topical application of vaccines does not generate sufficient immune response due to limited transport of vaccines across the stratum corneum of skin. Here we report that chemicals used in common skin products can enhance the immunogenicity of topically applied antigens. Six hundred formulations of commonly used chemicals were screened systematically for their potency (delivery of antigen) in vitro. A selected subset of these formulations was subsequently tested for their adjuvanticity (activation of immune response) in vitro. Lead formulations were tested in vivo for their ability to generate antibody titers against topically applied ovalbumin, a model antigen. Lead formulations were significantly more effective in generating anti-ovalbumin IgG titers. Our results demonstrate that chemical formulations can be successfully used to deliver antigens and that such formulations can be rationally designed by combinatorial screening of individual chemical components.

Mesh:

Substances:

Year:  2009        PMID: 19426770     DOI: 10.1016/j.jconrel.2009.05.003

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  12 in total

1.  Design and fabrication of human skin by three-dimensional bioprinting.

Authors:  Vivian Lee; Gurtej Singh; John P Trasatti; Chris Bjornsson; Xiawei Xu; Thanh Nga Tran; Seung-Schik Yoo; Guohao Dai; Pankaj Karande
Journal:  Tissue Eng Part C Methods       Date:  2013-12-31       Impact factor: 3.056

2.  Formulations for trans-tympanic antibiotic delivery.

Authors:  Xiaojuan Khoo; Emmanuel J Simons; Homer H Chiang; Julia M Hickey; Vishakha Sabharwal; Stephen I Pelton; John J Rosowski; Robert Langer; Daniel S Kohane
Journal:  Biomaterials       Date:  2012-11-09       Impact factor: 12.479

Review 3.  Mucosal vaccine delivery: Current state and a pediatric perspective.

Authors:  Akhilesh Kumar Shakya; Mohammed Y E Chowdhury; Wenqian Tao; Harvinder Singh Gill
Journal:  J Control Release       Date:  2016-02-06       Impact factor: 9.776

4.  Enabling skin vaccination using new delivery technologies.

Authors:  Yeu-Chun Kim; Mark R Prausnitz
Journal:  Drug Deliv Transl Res       Date:  2011-02-01       Impact factor: 4.617

5.  Novel topical microbicides through combinatorial strategies.

Authors:  Anubhav Arora; Samir Mitragotri
Journal:  Pharm Res       Date:  2010-03-20       Impact factor: 4.200

6.  Co-administration of protein drugs with gold nanoparticles to enable percutaneous delivery.

Authors:  Yongzhuo Huang; Faquan Yu; Yoon-Shin Park; Jianxin Wang; Meong-Cheol Shin; Hee Sun Chung; Victor C Yang
Journal:  Biomaterials       Date:  2010-09-09       Impact factor: 12.479

Review 7.  Cutaneous immunization: an evolving paradigm in influenza vaccines.

Authors:  Harvinder S Gill; Sang-Moo Kang; Fu-Shi Quan; Richard W Compans
Journal:  Expert Opin Drug Deliv       Date:  2014-02-12       Impact factor: 6.648

Review 8.  Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies.

Authors:  Samir Mitragotri; Paul A Burke; Robert Langer
Journal:  Nat Rev Drug Discov       Date:  2014-08-08       Impact factor: 84.694

Review 9.  Delivery systems for intradermal vaccination.

Authors:  Y C Kim; C Jarrahian; D Zehrung; S Mitragotri; M R Prausnitz
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

10.  Immunization with a MOMP-based vaccine protects mice against a pulmonary Chlamydia challenge and identifies a disconnection between infection and pathology.

Authors:  Connor P O'Meara; Charles W Armitage; Marina C G Harvie; Peter Timms; Nils Y Lycke; Kenneth W Beagley
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.